ArticleBlood advances2018

Sequential allogeneic and autologous CAR-T-cell therapy to treat an immune-compromised leukemic patient.

Jian-Ping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.